EQT completes sale of shares in Galderma Group AG
- Editor
- Jun 3
- 1 min read
Whats Happening:
EQT, a private equity fund, has completed the sale of 19,031,811 shares in Galderma Group AG through an accelerated bookbuilding process. The transaction resulted in total gross proceeds of approximately CHF 1.86 billion, with EQT receiving about CHF 494 million from the sale. The placement was finalized on June 2, 2025, with Goldman Sachs, Jefferies, Morgan Stanley, RBC, and UBS acting as joint global coordinators and joint bookrunners.
Key Moves:
EQT completes sale of 19,031,811 shares in Galderma Group AG
Total gross proceeds from the sale amount to CHF 1.86 billion
EQT receives approximately CHF 494 million from the transaction
By The Numbers:
Total gross proceeds: CHF 1.86 billion
EQT's share of proceeds: CHF 494 million
Number of shares sold: 19,031,811
Bottom Line:
EQT's successful sale of shares in Galderma Group AG demonstrates the fund's ability to execute large-scale transactions in the public markets. The substantial proceeds from this sale, totaling CHF 1.86 billion, with EQT receiving CHF 494 million, highlight the significant value creation achieved through this investment. This transaction represents an important exit for EQT and may provide capital for future investments or returns to its investors.
Comments